Brookdale Senior Living Inc. (NYSE:BKD) closed its last session at $16.46 with the change of +6.19%. The market capitalization of the company is $3.06B with an average Volume of 2.87 million shares. The stock currently has its 52-Week High range of $34.46 and 52-week low range of $11.28. The Price to Book (P/B) ratio stands at 1.19. The stock traded total quantity of 4.42 million shares.
For the current Fiscal Quarter, 7 analysts have given an average earnings per share forecast of $0.59. The Low Earnings per share estimate of the current Quarter is $0.56 and High Estimate is set at $0.6 according to these Analysts opinions. The Previous Year EPS of this Quarter is $0.6.
According to 5 analysts, an average sales Estimate of the current Fiscal quarter is $1.26B. The lower sales estimate is $1.25B and higher sales estimate is $1.27B according to these Analysts thoughts.
The Company currently has Highest Price Target of $30 and Lowest Price Target of $14.67. It has Median Price Targets of $22. Mean price target is set at $22.28 after consensus analysis of 6 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month 0 analysts have assigned this stock as Strong Buy where 0 assigned Buy, 4 analysts believe it’s a Hold, 1 said Underperform and 3 assigned Sell rating.
Array BioPharma Inc. (NASDAQ:ARRY) ended its last trade at $3.71 with the move of +0.82%. The company has market value of $532.16M with the total traded volume of 1.31 million. The stock currently has its 52-Week top value of $7.24 and 52-week down value of $2.38. . Its previous closing price was recorded at $3.68.
For the current Fiscal Quarter, 8 analysts have given an Average earnings estimate of $-0.14 per share. According to the Analysts, the Low Estimate Earnings of the current Quarter is $-0.27 while High Estimate is $0.09. The Previous Year EPS of this Quarter is $-0.09.
According to 8 analysts, an Average Revenue Estimate of the current Fiscal quarter is $41.51M. According to them, the Low Revenue estimate is $26.03M and High Revenue estimate is $58.00M.
The Company currently has High Price Target of $13. The Low and Mean Price Targets are $7 and $8.29 respectively. These price targets are set after consensus analysis of 7 brokers.
When having look at Recommendation Trends of the analysts polled at Thomson First call, for the Current month, 0 analysts have given this stock as Strong Buy where 0 issued Buy, 4 analysts think that it’s a Hold, 4 told Underperform and0 assigned Sell rating.